Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Concur Technologies Acquires GDSX, TRX

RELATED NEWS
Trade CNQR now with 

Concur Technologies Inc. (CNQR: Quote) announced it has acquired substantially all of the assets of GDSX, Ltd., a leader in Travel Management Company or TMC mid-office technology solutions.

Based in Dallas, GDSX provides cloud-based tools and services that enable mid-office automation, pre-trip authorization, trip disruption solutions and a centralized trip repository.

The terms of the transaction were not disclosed. Concur plans to provide updated guidance on July 31, 2013 when it reports financial results for the fiscal 2013 third quarter.

In a separate press release, Concur announced it acquired TRX Inc., a leader in travel data and Travel Management Company or "TMC" mid-office technology solutions. The terms of the acquisition were not disclosed.

Click here to receive FREE breaking news email alerts for Concur Technologies Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.